---
title: "MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286462189.md"
description: "MacroGenics, Inc. will participate in the Stifel 2026 Virtual Targeted Oncology Forum on May 20, 2026, at 10:30 a.m. ET. President and CEO Eric Risser will engage in a fireside chat to discuss innovative cancer treatments and the company's strategies in oncology. MacroGenics is listed on Nasdaq as MGNX and focuses on developing antibody-based therapies for cancer."
datetime: "2026-05-14T20:02:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286462189.md)
  - [en](https://longbridge.com/en/news/286462189.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286462189.md)
---

# MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum

Rockville, Maryland - May 14, 2026 - MacroGenics, Inc., a biopharmaceutical company specializing in developing antibody-based therapies for cancer treatment, shared news that its President and CEO, Eric Risser, will engage in a fireside chat at the Stifel 2026 Virtual Targeted Oncology Forum on May 20, 2026, at 10:30 a.m. ET. The event aims to provide insights on innovative cancer treatments. MacroGenics, Inc. is listed on Nasdaq as MGNX, catering to developing groundbreaking therapies. This forum signifies a pivotal opportunity for the company's leadership to discuss its strategies and advancements in the field of oncology.

### Related Stocks

- [MGNX.US](https://longbridge.com/en/quote/MGNX.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [MacroGenics Q1 revenue rises, beats estimates on client production and cancer drug royalties](https://longbridge.com/en/news/286310410.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)
- [Zydus buys US specialty drugmaker Assertio in Rs 1,600 crore all-cash deal](https://longbridge.com/en/news/286352725.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)